Abstract:Heterogeneity of neurodegenerative diseases, including Alzheimer’s disease (AD), has hampered precision diagnosis and prognosis. Machine learning methods are able to dissect neuroanatomical heterogeneity and enable identification of disease subtypes via their imaging signatures. We apply a novel semi‐supervised deep‐learning clustering method to derive dimensions of neurodegeneration, and investigate longitudinal paths in this dimensional system. Analyses used structural MRIs (from the Alzheimer’s Disease Neuroimaging Initiative and the Baltimore Longitudinal Study of Aging; total 2,832 participants; 8,146 scans) including controls and patients with Mild Cognitive Impairment (MCI) and AD. Smile‐GAN identified 4 neurodegenerative patterns/axes (Figure 1): P1, normal anatomy; P2, mild/diffuse atrophy; P3, focal medial temporal atrophy; P4, advanced neurodegeneration. Further application to longitudinal data revealed two distinct progression pathways: P1→P2→P4 and P1→P3→P4. Clinically, P2 participants showed worse performance in executive function than P3 participants (median ADNI‐EF= ‐0.29 vs. ‐0.1, with p=0.038) but had better memory (ADNI‐MEM= ‐0.13 vs. ‐0.39, with p=0.003) (Figure 2). Progression to P4 occurred more rapidly from P3 than P2, with median survival time to progression of 4.5 years and 3.2 years for P2 and P3 MCI/Dementia participants, respectively. Baseline expression of these patterns predicted the pathway and rate of future neurodegeneration, with high accuracy for determining whether P1 participants would progress and whether they would progress to P2 or P3 (Cox‐proportional‐hazard model average concordance index (CI) on the validation set of 0.8±0.02). Pattern expression offered better performance (CI=0.72±0.02) in predicting clinical conversion from MCI to Dementia compared to amyloid/tau (CI=0.69±0.02), with all three together showing modest improvement over pattern performance (CI=0.76±0.02). A composite risk score comprised of pattern probabilities, Abeta, pTau, presence of APOE E4, and ADAS‐cog score was able to predict survival time with an average concordance index, 0.78±0.02 on randomly split validation sets. (Figure 3). Four reproducible volumetric patterns, and 2 major longitudinal pathways were revealed using deep learning, which can be determined on an individual patient basis and has implications for rate of future decline. These pattern‐based biomarkers can enrich the N‐dimension of the A/T/N framework which may inform on clinical trial enrollment and monitoring outcomes in a more personalized manner.

Voxel-Level Fmri Analysis by Representation Learning and Deep Clustering for Alzheimer's Disease.

Regional Brain Fusion: Graph Convolutional Network for Alzheimer's Disease Prediction and Analysis

Contrastive voxel clustering for multiscale modeling of brain network

Multigroup Recognition of Dementia Patients with Dynamic Brain Connectivity under Multimodal Cortex Parcellation

Functional Brain Network Measures for Alzheimer's Disease Classification

Research on Voxel-Based Features Detection and Analysis of Alzheimer's Disease Using Random Survey Support Vector Machine

Quantification of Cognitive Function in Alzheimer’s Disease Based on Deep Learning

Research on Pathogenic Hippocampal Voxel Detection in Alzheimer's Disease Using Clustering Genetic Random Forest

The Identification of Alzheimer’s Disease Using Functional Connectivity Between Activity Voxels in Resting-State fMRI Data

Interpretable Graph Convolutional Network Of Multi-Modality Brain Imaging For Alzheimer’s Disease Diagnosis

Dynamic Functional Connectivity and Graph Convolution Network for Alzheimer's Disease Classification

Deep Learning-Based Classification and Voxel-Based Visualization of Frontotemporal Dementia and Alzheimer’s Disease

Alzheimer's Disease Early Diagnosis Based on Resting-State Dynamic Functional Connectivity

Multivariate Deep Learning Classification of Alzheimer’s Disease Based on Hierarchical Partner Matching Independent Component Analysis

Topology-based Clustering of Functional Brain Networks in an Alzheimer's Disease Cohort

Multimodal Data Analysis of Alzheimer's Disease Based on Clustering Evolutionary Random Forest

Biomarker Investigation using Multiple Brain Measures from MRI through XAI in Alzheimer's Disease Classification

Intrinsic Functional Component Analysis Via Sparse Representation on Alzheimer's Disease Neuroimaging Initiative Database.

Biomarkers Derived from Alterations in Overlapping Community Structure of Resting-state Brain Functional Networks for Detecting Alzheimer’s Disease

A Novel Longitudinal Phenotype-Genotype Association Study Based on Deep Feature Extraction and Hypergraph Models for Alzheimer's Disease

Disentangling brain heterogeneity via semi‐supervised deep‐learning and MRI: Application to dimensional representations of Alzheimer’s disease